Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq
Other stock markets
 03:59:50 2024-07-12 pm EDT 		5-day change 1st Jan Change
1.31 USD -0.76% Intraday chart for Altamira Therapeutics +2.34% -62.36%
Jun. 20 Altamira Therapeutics Ltd. Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management CI
May. 16 Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Revisions Altamira Therapeutics